Watson Laboratories, Inc. vs. United Therapeutics Corp.
Explore the PTAB proceeding IPR2017-01621 filed by Watson Laboratories, Inc. on 2017-06-21. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2017-01621
Filing Date
2017-06-21
Accorded Filing Date
2017-06-21
Institution Decision Date
2018-01-11
Last Modified Date
2019-03-19
Proceeding Type
IPR
Termination Date
2018-08-27
Trial Status
Terminated-Settled
Parties & Counsel
Petitioner
Watson Laboratories, Inc.
Represented By
Michael NutterPatent Owner / Respondent
United Therapeutics Corp.
Represented By
Stephen MaebiusPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
2 Total
Proceeding Status
Terminated-Settled
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (2)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 34702 | Andrew Rawlins | +1 202-672-5349 |
| 35264 | Stephen Maebius | +1 202-672-5569 |
| 37288 | Courtenay Brinckerhoff | +1 202-672-5300 |
| 47358 | Andrew Mitchell | +1 414-297-5722 |
| 55600 | Kristel Schorr | +1 202-672-5300 |
| 56439 | Alexey Saprigin | +1 202-295-4632 |
| 59349 | Benjamin Berkowitz | +1 202-672-5300 |
| 59987 | Shaun Snader | +1 -- |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 11 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | US 9,358,240 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 9,339,507 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 10,376,525 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2019036577 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 10,716,793 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 11,357,782 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2022021872 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2022032345 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2023006260 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 80,001,606 P | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2008020044 | US Continuation / Sibling | View Official Patent → |
Liquidia Technologies, Inc. v. United Therapeutics Corporation
Watson Laboratories, Inc. v. United Therapeutics Corp.
UNITED THERAPEUTICS CORPORATION v. LIQUIDIA TECHNOLOGIES, INC.